Latest Boardroom Shifts News

Page 115 of 170
VDM Group remains suspended from ASX trading amid a legal dispute over its Angolan joint ventures, while pivoting towards new critical minerals opportunities in Australia.
Maxwell Dee
Maxwell Dee
7 Aug 2025
Papyrus Australia appoints Daniel Schmidt as CEO to lead its transition from R&D to commercial operations, alongside a strategic restructure to support growth.
Maxwell Dee
Maxwell Dee
7 Aug 2025
Finexia Financial Group has resumed trading following announcements of a significant business disposal and new executive appointments, signaling a pivotal restructuring phase.
Claire Turing
Claire Turing
7 Aug 2025
Key Petroleum Limited has appointed Yan Zhao as Managing Director, bringing over two decades of mining and exploration expertise to the helm. The move signals potential strategic shifts amid a modest remuneration package.
Maxwell Dee
Maxwell Dee
7 Aug 2025
IDT Australia announces the immediate resignation of CEO Paul McDonald, appointing Executive Chair Mark Simari to lead as the company reports a 40.6% revenue increase but a widening net loss for FY25.
Victor Sage
Victor Sage
7 Aug 2025
360 Capital Mortgage REIT has confirmed comprehensive compliance with ASX corporate governance principles for FY2025, with a single noted exception regarding board chair independence.
Victor Sage
Victor Sage
7 Aug 2025
Articore Group has appointed CEO Vivek Kumar as Managing Director, underscoring the board’s confidence following a record-breaking quarter and strategic turnaround efforts.
Victor Sage
Victor Sage
6 Aug 2025
FirstWave’s Q4 FY25 update reveals a slight revenue decline but highlights a strategic AWS partnership and new chairman appointment, signaling a pivotal growth phase.
Sophie Babbage
Sophie Babbage
6 Aug 2025
ChemX Materials Limited has explained the delayed filing of director interest notices, attributing it to transitional challenges during its recent recapitalisation and governance overhaul.
Maxwell Dee
Maxwell Dee
5 Aug 2025
Platinum Capital Limited has pulled its proposed scheme of arrangement due to insufficient shareholder support but will proceed with an on-market buy-back. Meanwhile, L1 Capital pushes for management control and board renewal.
Claire Turing
Claire Turing
5 Aug 2025
Vitrafy Life Sciences reported a $32.7 million loss for FY25, driven by investments in its next-generation cryopreservation platform following a $35 million IPO and a $4.8 million government grant. The company is progressing commercialization efforts with key partnerships in human and animal health.
Ada Torres
Ada Torres
5 Aug 2025
Vitrafy Life Sciences announces a leadership change with CEO Kate Munnings retiring and co-founder Brent Owens stepping up to lead the company’s next growth phase.
Ada Torres
Ada Torres
5 Aug 2025